Propulsid
may
cause
irregular
heartbeats
and
even
sudden
death.
At
least
341
reports
of
heart-rhythm
abnormalities,
including
80
reports
of
deaths,
have
been
associated
with
Propulsid.
Although
the
FDA
first
warned
that
Propulsid
can
cause
serious
heart
problems
in
June
1998,
reports
of
deaths
and
hospitalizations
have
continued
to
mount.
If
you
feel
you
have
a
case
regarding
the
usage
of
propulsid, Click
Here
for
a
Free
Propulsid
Case
Evaluation.
Some
30
million
U.S.
residents,
including
President
Clinton,
have
taken
the
medication
since
it
hit
the
market
in
1993
for
Gastroesophageal
Reflux
Disease
(GERD).
If
you
believe
that
you
or a
loved
one
has
been
injured
by a
product
containing
Propulsid
consult
a
lawyer
to
learn
your
legal
rights.
After
the
drug's
approval
in
1993,
there
were
several
revisions
to
the
Propulsid
label,
informing
health
care
professionals
and
patients
about
various
side
effects
and
risks,
the
most
serious
of
which
involved
cardiac
irregularities.
Propulsid
can
cause
serious
side
effects
such
as:
Sudden
cardiac
death,
Heart
attack,
Irregular
heartbeat,
and
QT
interval
prolongation.
Although
Propulsid
was
only
associated
with
mild
adverse
effects
upon
approval,
the
drug
was
soon
linked
to
life-threatening
heart
rhythm
abnormalities
(arrhythmias)
and
cardiac
arrest
in
people
with
no
prior
heart
disease.
After
years
of
escalating
fatalities
and
pressure
from
the
FDA,
Janssen
Pharmaceutical
Inc.,
a
division
of
Johnson
&
Johnson,
announced
that
it
would
voluntarily
stop
marketing
Propulsid
in
the
United
States
beginning
July
14,
2000.
Click
Here
for
a
Free
Propulsid
Case
Evaluation. |
|
|
|